ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Callisto Pharmaceuticals,

Callisto Pharmaceuticals, (KAL)

0.00
0.00
(0.00%)
Cerrado 08 Diciembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

KAL Últimas noticias

Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal -

Callisto Pharmaceuticals, Inc. (AMEX: KAL), announced today that on April 7, 2008, it received notice from the American Stock Exchange indicating that AMEX intends to strike the...

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

Callisto Pharmaceuticals, Inc. Receives Notice From AMEX

NEW YORK, June 22 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (AMEX:KAL), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
UAMYUnited States Antimony Corp
US$ 1.895
(40.37%)
20.28M
GPUSHyperscale Data Inc
US$ 6.79
(36.35%)
647.91k
CHROChannel Therapeutics Corporation
US$ 0.8349
(26.31%)
1.09M
ROLRHigh Roller Technologies Inc
US$ 6.60
(16.40%)
29.63k
DSSDSS Inc
US$ 1.04
(12.95%)
93.24k
CTMCastellum Inc
US$ 0.28675
(-18.07%)
6.51M
PWPower REIT
US$ 1.90
(-16.30%)
1.06M
UMACUnusual Machines Inc
US$ 8.66
(-15.51%)
4.17M
UAVSAgEagle Aerial Systems Inc
US$ 5.735
(-14.40%)
1.82M
SCPXScorpius Holdings Inc
US$ 0.3978
(-13.75%)
515.71k
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 0.9556
(-4.11%)
614.58M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 29.61
(1.68%)
49.15M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3.165
(3.77%)
39.96M
SPYSPDR S&P 500
US$ 607.81
(0.19%)
30.8M
TZADirexion Daily Small Cap Bear 3X Share New
US$ 10.485
(-1.08%)
30.58M
Jefedejefes Jefedejefes 8 minutos hace
Why do you say this unless you are part of the scam? I have volumes of misrepresented "facts" and continuing to build.


EDXC
Ranb2khz Ranb2khz 10 minutos hace
O Holy Night – Michael Crawford (Live from Bethlehem) (1999)

[yt]KlKtkQ10GL0[/yt]

https://www.youtube.com/watch?v=KlKtkQ10GL0






stockrider stockrider 14 minutos hace
GRLT - Merged company Primior has $1.5 Billion in asset that they are managing as per last PR, that's right in billion..People missed this key part of the PR, once masses realizes how big this merger is which is already completed this is going to run wild soon..At 3.8B OS, even with pps at 0.10, mar
GRLT
stockrider stockrider 17 minutos hace
Primior has $1.5 Billion in asset that they are managing as per last PR, that's right in billion..People missed this key part of the PR, once masses realizes how big this merger is which is already completed this is going to run wild soon..At 3.8B OS, even with pps at 0.10, market cap will be still
GRLT
sab63090 sab63090 25 minutos hace
Leo
With the stock price now trading at an important spot, I take the position along with other factors that the risk/reward right now is pretty good for a trader even if you go flat on weekends... $8 or so offers a trader pretty good odds for a push up towards $9 and I believe you go for .50
AVXL
Ribo Ribo 32 minutos hace
Current and merger with a large Asian tech company will be announced??!!😆

https://stocktwits.com/mstep1/message/595496867
EEGI
Ranb2khz Ranb2khz 33 minutos hace
How Many Kings – Downhere (lyrics)

[yt]WTYe9sWYKdo[/yt]

https://www.youtube.com/watch?v=WTYe9sWYKdo






sab63090 sab63090 33 minutos hace
Investor
It seems to me that there has been progress albeit with incomplete data reported and information supplied to inform shareholders of this lacking data which was apparently supplied for the MAA filing. Maybe that's normal?

I really don't think Missling and others deserv
AVXL
cojoboy cojoboy 43 minutos hace
I know right..???..smh...If he came at me I would understand that...lol..💪💪💪💪
RDAR
HGilS HGilS 1 hora hace
You are an ib_ worshipper!!!

lol hahaha.

Nasrat 4 more years lol.
ELTP
walterc walterc 1 hora hace
what is incoherent and childish is writing almost 2000 messages complaining EVERY DAY whereby you invested 20 years ago in a stock when the risk was extremely high and nobody in the sector believed polymers had a future. Now that we are on the roadmap of Photon Delta and close to acceptance by th
LWLG
PC retired PC retired 2 horas hace
Hi RichardH2, you left out the Powertron debacle. Powertron were foolish enough to advance $1million without doing a comprehensive DD. Having done the DD the next installment of $4million was obviously cancelled.
ASRE
surrealistrader surrealistrader 2 horas hace
Clearly Steve Cyros tampers with his handheld XRF....

...and his same hairy hand on that sci-aps device showing bogus results somehow find their way into company disclosures and social media posts on the regular. It's hard to say that these guys have taken a turn at some point, becaus
SDRC
thistraderknowsall thistraderknowsall 2 horas hace
SUKU flys to $1+ on the AI news!! We rich!!

They mentioned SUKU will do a FARM
run up!!! $68!!!!
Guzzi62 Guzzi62 2 horas hace
From the article:

OUR PICKS FOR 2025

NWBO and SHPH Groundbreaking Cancer Treatment Combo
December 7, 2024|Revolutionary cancer treatment

1. Northwest Biotherapeutics' DCVax-L and Shuttle Pharmaceuticals' Ropidoxuridine show groundbreaking results
NWBO SHPH
Guzzi62 Guzzi62 2 horas hace
Thanks JonnyShooter on Stocktwits.

https://kingofpennystock.com/f/nwbo-and-shph-groundbreaking-cancer-treatment-combo
NWBO
SilkRoad SilkRoad 2 horas hace
The rate you are using to say they won’t make a metric ton for three years is not the rate at which they are operating at now especially when they say they expect to make 10,000 pounds of spider silk yarn in 2025 and Dr. Kumar said multi-tons of silk will be made in 2025. Note Kim said yarn, not co
KBLB
thistraderknowsall thistraderknowsall 2 horas hace
SUKU Altcoin crypto flys $1 to $5+ on the AI news!! We rich!! #1Trending!!!!
SilkRoad SilkRoad 2 horas hace
Well said mojo.
KBLB
SilkRoad SilkRoad 2 horas hace
Thank you.
KBLB

Su Consulta Reciente

Delayed Upgrade Clock